Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bayesian dose adaptation of tacrolimus and mycophenolate mofetil after lung transplantation
2008-008137-11Phase 4Active
- Sponsor
- CHU de Limoges
- Start
- Mar 2009
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tacrolimus and mycophenolate mofetil in Not applicable (the term "lung transplant recipient" does not refer to a disease) and heart-lung transplant recipient status (2 arms), sponsored by CHU de Limoges. Primary endpoint: Immunosuppressive treatment failure. Started Mar 2009; status: active.
02
Drugs
tacrolimusmycophenolate mofetil
03
Conditions
Not applicable (the term "lung transplant recipient" does not refer to a disease)heart-lung transplant recipient status
Beyond the preview
Go deeper on 2008-008137-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008137-11.